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bilaterality) that resemble stress or insufficiency fractures of
the subtrochanteric or diaphyseal part of the femur. They often
occur in subjects with long-term antiresorptive therapies, but
are also observed in antiresorptive drugs-naive patients or in
patients with monogenetic bone disorders, suggesting a genet-
ic susceptibility. Other factors influence their pathogenesis,
including some clinical risk factors (autoimmune disease and
glucocorticoids use, Asian ethnicity), hip and lower limb ge-
ometry, and changes in bone material properties.
In this session, we will discuss:
– How to identify subtrochanteric or diaphyseal fractures of
the femur which satisfy the case definition of AFF pro-
posed by the ASBMR Task Force.
– The epidemiology of AFF in comparison to those of os-
teoporotic fractures prevented by antiresorptive therapy.
– How to monitor patients on long-term antiresorptive ther-
apy for incomplete AFFs prior to fracture.
– The clinical management of patients who sustained an
AFF, which is balanced by the risk of second AFF and
the need to prevent future fragility fractures.
– Whether teriparatide may be of some benefit in acceler-
ating AFF fracture healing.
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Vertebral fractures are the most common osteoporotic frac-
tures, and their consequences in morbidity and mortality are
well recognized. The diagnosis of vertebral fractures is based
on spine X-rays, but under diagnosis has been reported by
many studies. This is explained in part by the absence of gold
standard for definition of fractures and by the high number of
deformities of vertebral bodies, which are not of osteoporotic
origin.
Computed tomography (CT) and magnetic resonance imaging
(MRI) are very sensitive and specific but have high costs, and,
in the case of CT, expose individuals to relatively high
amounts of radiation. Densitometric vertebral fracture assess-
ment (VFA) has the advantage of potentially reducing the
impact of parallax effects on fracture identification with little
expense and low radiation exposure.
Accurate identification of osteoporotic vertebral fractures and
appropriate treatment are needed to reduce the impact of the
disease on patients and on the health care system.
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According to an ESCEO-EUGMS survey, 53.3% of clinicians
assess muscle mass in daily practice, 54.5% muscle strength
and 71.4% physical performance. However, the tools used are
very different and no single tool is used by all clinicians.
However, the tools and the cut-off values used by clinicians
to diagnose various disorders such as sarcopenia are also het-
erogeneous. Interestingly, the relationship between muscle
strength and physical function is influenced by level of muscle
mass, the degree of obesity (e.g. BMI), age and physical ac-
tivity. Therefore, these factors are to be taken into account in
the evaluation of muscle strength. According to the revised
European consensus on sarcopenia, muscle strength is the
primary parameter of sarcopenia and is associated with ad-
verse outcomes or physical limitation. However, it is neces-
sary to have objective, reliable and sensitive tools to assess
muscle strength, in different populations to detect and quantify
weakness, and to evaluate the effects of treatment. Handgrip
strength measurement may be suitable for clinical practice
while the measurement of knee flexors/extensors strength
with both 1RM and dynamometers is more relevant but lim-
ited by the need for special equipment.
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